Hikma Pharmaceuticals Plc Current Ratio 2016-2020 | HKMPF

Current and historical current ratio for Hikma Pharmaceuticals Plc (HKMPF) from 2016 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Hikma Pharmaceuticals Plc current ratio for the three months ending June 30, 2020 was .
Hikma Pharmaceuticals Plc Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2020-06-30 $1.88B $1.07B 1.76
2019-12-31 $1.85B $1.47B 1.26
2019-06-30 $1.70B $1.32B 1.28
2018-12-31 $1.67B $0.89B 1.87
2018-06-30 $1.55B $0.81B 1.90
2017-12-31 $1.57B $0.80B 1.98
2017-06-30 $1.47B $0.77B 1.90
2016-12-31 $1.45B $0.92B 1.58
2015-12-31 $1.36B $0.59B 2.30
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $8.532B $2.207B
Hikma Pharmaceuticals PLC develops, manufactures and markets pharmaceutical products. Its brand portfolio includes branded, injectables and generic. Branded segment offers dosage forms and strengths in the anti-infective, cardiovascular, diabetes, central nervous system, oncology and respiratory. Injectables segment offers dosage for CNS, controlled substances, anti-infective, cardiovascular and oncology in form of liquid, semi-liquid and powdered form. Generics segment offers dosage for therapeutic including analgesic, anti-infective, anti-inflammatory, cardiovascular, CNS, respiratory and hormonal. Hikma Pharmaceuticals PLC is based in London, the United Kingdom.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.680B 41.80
Takeda Pharmaceutical (TAK) Japan $57.916B 10.81
Astellas Pharma (ALPMY) Japan $30.701B 19.17
Eisai (ESALY) Japan $22.474B 19.58
Merck (MKGAF) Germany $22.165B 0.00
UCB SA (UCBJF) Belgium $20.763B 0.00
Catalent (CTLT) United States $19.060B 57.01
Grifols, S.A (GRFS) Spain $13.050B 14.94
Neurocrine Biosciences (NBIX) United States $11.155B 87.79
Jazz Pharmaceuticals (JAZZ) Ireland $9.526B 15.39
Ionis Pharmaceuticals (IONS) United States $8.918B 87.37
Arrowhead Pharmaceuticals (ARWR) United States $8.645B 0.00
United Therapeutics (UTHR) United States $7.526B 16.02
IPSEN SA ADR (IPSEY) France $7.292B 0.00
STADA ARZNEIMI (STDAF) Germany $6.884B 0.00
Orion OYJ (ORINY) Finland $6.427B 22.30
Evotec AG (EVTCY) Germany $5.923B 401.50
Sage Therapeutics (SAGE) United States $4.708B 0.00
FibroGen (FGEN) United States $4.513B 0.00
ChemoCentryx (CCXI) United States $4.486B 0.00
PTC Therapeutics (PTCT) United States $4.334B 0.00
Hypermarcas (HYPMY) Brazil $4.187B 16.52
Cronos Group (CRON) Canada $3.526B 0.00
Corcept Therapeutics (CORT) United States $3.318B 32.09
Nektar Therapeutics (NKTR) United States $3.183B 0.00
Pacira BioSciences (PCRX) United States $3.032B 65.85
Taro Pharmaceutical Industries (TARO) Israel $2.938B 15.00
Revolution Medicines (RVMD) United States $2.861B 0.00
Xencor (XNCR) United States $2.796B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.371B 0.00
Tilray (TLRY) Canada $2.295B 0.00
USANA Health Sciences (USNA) United States $1.884B 16.58
Translate Bio (TBIO) United States $1.831B 0.00
Endo (ENDP) Ireland $1.677B 2.55
Ironwood Pharmaceuticals (IRWD) United States $1.671B 14.30
Heron Therapeutics (HRTX) United States $1.661B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.617B 0.00
Ocular Therapeutix (OCUL) United States $1.580B 0.00
ImmunoGen (IMGN) United States $1.505B 0.00
Indivior (INVVY) United States $1.467B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.454B 10.10
Trillium Therapeutics (TRIL) Canada $1.324B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.178B 0.00
Karyopharm Therapeutics (KPTI) United States $1.156B 0.00
Organogenesis Holdings (ORGO) United States $1.122B 0.00
VAXART, INC (VXRT) United States $1.100B 0.00
Zogenix (ZGNX) United States $1.092B 0.00
Radius Health (RDUS) United States $0.990B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.967B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Vectura Group (VEGPF) United Kingdom $0.925B 0.00
Aerie Pharmaceuticals (AERI) United States $0.853B 0.00
Collegium Pharmaceutical (COLL) United States $0.846B 49.92
Esperion Therapeutics (ESPR) United States $0.803B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.770B 0.00
Aclaris Therapeutics (ACRS) United States $0.757B 0.00
Acutus Medical (AFIB) United States $0.732B 0.00
Ardelyx (ARDX) United States $0.694B 0.00
Chinook Therapeutics (KDNY) United States $0.679B 0.00
Sundial Growers (SNDL) Canada $0.665B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.622B 0.00
Flexion Therapeutics (FLXN) United States $0.603B 0.00
Molecular Templates (MTEM) United States $0.597B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.572B 0.00
Altimmune (ALT) United States $0.559B 0.00
Akebia Therapeutics (AKBA) United States $0.536B 0.00
Siga Technologies (SIGA) United States $0.532B 14.94
Harpoon Therapeutics (HARP) United States $0.531B 0.00
Jounce Therapeutics (JNCE) United States $0.524B 0.00
PROFOUND MEDICL (PROF) Canada $0.524B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.502B 0.00
Summit Therapeutics (SMMT) United States $0.497B 0.00
DURECT (DRRX) United States $0.486B 0.00
TherapeuticsMD (TXMD) United States $0.483B 0.00
Menlo Therapeutics (VYNE) United States $0.443B 0.00
CASI Pharmaceuticals (CASI) United States $0.429B 0.00
Rafael Holdings (RFL) United States $0.402B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.397B 0.00
Jaguar Animal Health (JAGX) United States $0.392B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.385B 10.03
Innate Pharma SA (IPHYF) France $0.371B 0.00
MEI Pharma (MEIP) United States $0.343B 0.00
Concert Pharmaceuticals (CNCE) United States $0.341B 0.00
Lannett Co Inc (LCI) United States $0.331B 8.71
Matinas Biopharma Holdings (MTNB) United States $0.327B 0.00
Nature's Sunshine Products (NATR) United States $0.314B 20.19
Alpine Immune Sciences (ALPN) United States $0.303B 0.00
Redhill Biopharma (RDHL) Israel $0.296B 0.00
KalVista Pharmaceuticals (KALV) United States $0.295B 0.00
Xeris Pharmaceuticals (XERS) United States $0.274B 0.00
CTI BioPharma (CTIC) United States $0.254B 0.00
Infinity Pharmaceuticals (INFI) United States $0.254B 0.00
IMV INC (IMV) Canada $0.242B 0.00
Otonomy (OTIC) United States $0.233B 0.00
OptiNose (OPTN) United States $0.232B 0.00
Calithera Biosciences (CALA) United States $0.226B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.218B 0.00
Oncternal Therapeutics (ONCT) United States $0.213B 0.00
Taiwan Liposome (TLC) Taiwan $0.192B 0.00
IsoRay (ISR) United States $0.192B 0.00
Novan (NOVN) United States $0.191B 0.00
Aquestive Therapeutics (AQST) United States $0.190B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.188B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.184B 0.00
Heat Biologics (HTBX) United States $0.183B 0.00
ProPhase Labs (PRPH) United States $0.182B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.170B 0.00
Champions Oncology (CSBR) United States $0.162B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.155B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.155B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.153B 0.00
Lipocine (LPCN) United States $0.145B 0.00
Onconova Therapeutics (ONTX) United States $0.142B 0.00
MediWound (MDWD) Israel $0.139B 0.00
ElectroCore (ECOR) United States $0.125B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.122B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.116B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.098B 0.00
Nutriband (NTRB) United States $0.092B 0.00
Iterum Therapeutics (ITRM) Ireland $0.089B 0.00
Hemispherx BioPharma (AIM) United States $0.089B 0.00
Biomerica (BMRA) United States $0.088B 0.00
KemPharm (KMPH) United States $0.088B 0.00
Natural Alternatives (NAII) United States $0.086B 165.37
SCYNEXIS (SCYX) United States $0.084B 0.00
Recro Pharma (REPH) United States $0.083B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.081B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.074B 0.00
AgeX Therapeutics (AGE) United States $0.073B 0.00
Vical (BBI) United States $0.069B 0.00
CV Sciences (CVSI) United States $0.066B 0.00
India Globalization Capital (IGC) United States $0.064B 0.00
Addex Therapeutics (ADXN) Switzerland $0.064B 0.00
PolarityTE (PTE) United States $0.061B 0.00
Trimel Pharmaceuticals (ASPCF) Canada $0.057B 0.00
RENEURON GP (RNUGF) United Kingdom $0.057B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.053B 0.00
Regulus Therapeutics (RGLS) United States $0.050B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.050B 25.39
Neos Therapeutics (NEOS) United States $0.044B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.043B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.040B 0.00
Mannatechorporated (MTEX) United States $0.040B 5.88
Can-Fite Biopharma (CANF) Israel $0.032B 0.00
Midatech Pharma (MTP) United Kingdom $0.031B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.031B 0.00
Flex Pharma (SLRX) United States $0.031B 0.00
China SXT Pharmaceuticals (SXTC) China $0.022B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.022B 0.00
Cyanotech (CYAN) United States $0.021B 33.95
HANCOCK JAFFE (HJLI) United States $0.020B 0.00
Xenetic Biosciences (XBIO) United States $0.017B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.017B 0.00
RXi Pharmaceuticals (PHIO) United States $0.017B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.015B 0.00
SHINECO INC (TYHT) China $0.011B 0.00
JanOne (JAN) United States $0.010B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00